References
- Park KC, Gaze DC, Collinson PO, et al. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708–1718.
- Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–877.
- Ostermann Μ, Ayis S, Tuddenham E, et al. Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock. 2017;47(6):702–708.
- Vallabhajosyula S, Sakhuja A, Geske JB, et al. Role of admission Troponin-T and serial Troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017;6(9):e005930.
- Dirchwolf M, Podhorzer A, Marino M, et al. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Cytokine. 2016;77:14–25.
- Sipeki N, Antal-Szalmas P, Lakatos PL, et al. Immune dysfunction in cirrhosis. World J Gastroenterol. 2014;20(10):2564–2577.
- Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385–1396.
- Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–1437,1437.e1-9.
- Arroyo V, Angeli P, Moreau R, investigators from the EASL-CLIF Consortium, Grifols Chair and European Foundation for the Study of Chronic Liver Failure (EF-Clif), et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2021;74(3):670–685.
- Moreau R. The pathogenesis of ACLF: the inflammatory response and immune function. Semin Liver Dis. 2016;36(2):133–140.
- Watt KDS, Coss E, Pedersen RA, et al. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010;16(8):990–998.
- Coss E, Watt KDS, Pedersen R, et al. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011;17(1):23–31.
- Snipelisky D, Donovan S, Levy M, et al. Cardiac troponin elevation predicts mortality in patients undergoing orthotopic liver transplantation. J Transplant. 2013;2013:1–6.
- Park J, Lee SH, Han S, et al. Preoperative cardiac troponin level is associated with all-cause mortality of liver transplantation recipients. PLoS ONE. 2017;12(5):e0177838.
- Parekh NK, Hynan LS, De Lemos J, Acute Liver Failure Study Group, et al. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology. 2007;45(6):1489–1495.
- Audimooolam VK, McPhail MJW, Sherwood R, et al. Elevated troponin I and its prognostic significance in acute liver failure. Crit Care. 2012;16(6):R228.
- Elnegouly M, Umgelter K, Safi W, et al. Elevated cardiac troponin T in cirrhotic patients with emergency care admissions: Associations with mortality. J Gastroenterol Hepatol. 2018;33(2):518–523.
- Collet JP, Thiele H, Barbato E, ESC Scientific Document Group, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367.
- Jalan R, Pavesi M, Saliba F, CANONIC Study Investigators; EASL-CLIF Consortium, et al. The CLIF consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol. 2015;62(4):831–840.
- Jalan R, Saliba F, Pavesi M, CANONIC study investigators of the EASL-CLIF Consortium, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038–1047.
- Thygesen M, Alpert JS, Jaffe AS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264.
- Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the infectious diseases society of america (IDSA) and the American society for microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22–e121.
- Angeli P, Bernardi M, Villanueva C, et al. European association for the study of the liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
- ARCHITECT STAT High Sensitive Troponin-I [package insert, G97079R01]. Lake Bluff, Illinois: Abbott Laboratories 2018.
- Pateron D, Beyne P, Laperche T, et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology. 1999;29(3):640–643.
- Wiese S, Mortensen C, Gøtze JP, et al. Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int. 2014;34(6):e19-30–e30.
- Collinson P. The role of cardiac biomarkers in cardiovascular disease risk assessment. Curr Opin Cardiol. 2014;29(4):366–371.
- McEvoy JW, Chen Y, Nambi V, et al. High-Sensitivity cardiac troponin T and risk of hypertension. Circulation. 2015;132(9):825–833.
- McEvoy JW, Chen Y, Ndumele CE, et al. Six-Year change in High-Sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol. 2016;1(5):519–528.
- Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. 2010;53(1):179–190.
- Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011;7:597–603.
- Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548.
- Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(9):727–738.
- Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3–11.
- Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 2006;129(5):1349–1366.
- Moore JK, Craig DG, Pryde EA, et al. Persistently elevated troponin I in paracetamol hepatotoxicity: association with liver injury, organ failure, and outcome. Clin Toxicol (Phila). 2013;51(7):532–539.